glp-1 receptor agonist mechanism GLP1 Agonists—Effects beyond Obesity and Diabetes Trends in the Development of
Description
Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.
adults have obesity, with the rate increasing more than 10 percentage points in the past 2 decades
Not for human or veterinary use
Not approved for diagnostic, therapeutic, or medical applications
Why PatchAid
